Form 4 for CUE Cue Biopharma, Inc.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0001209191-22-022578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-04 | 2022-03-31 | CUE | Suri Anish | Pres AND CSO | F - Tax | $4.88 | -7,068 | 103.6K | -6% | -$34.5K |
| D | 2022-04-04 | 2022-03-31 | CUE | Suri Anish | Pres AND CSO | M - OptEx | — | +16.7K | 110.7K | +18% | — |
| D | 2022-04-04 | 2022-03-31 | CUE | Suri Anish | Pres AND CSO | M - OptEx | $0.00 | -16.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | F | D | 7,068 | $4.88 | 103,638 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-31 | M | A | 16,668 | — | 110,706 | D | — | — | (F1) Represents shares of common stock received upon vesting of a restricted stock unit award |
| 3 | Derivative | Restricted Stock Units | 2022-03-31 | M | D | 16,668 | $0.00 | 0 | D | — · — to — | 16,668 Common Stock | (F2) Each restricted stock unit award represents a contingent right to receive one share of common stock. (F3) The restricted stock units vest in three equal annual installments beginning on March 31, 2020. |